Hive drug trial halted: new hope for Cold-Triggered itch?
NCT ID NCT06353971
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This trial tested a single dose of a drug called briquilimab in adults with chronic hives caused by cold or pressure that antihistamines couldn't control. The study aimed to check safety and see if it reduces symptoms. However, the trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INDUCIBLE URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - University Clinic Berlin
Berlin, 12203, Germany
-
University Clinic Schleswig-Holstein
Lübeck, 23538, Germany
-
University Hospital Dresden
Dresden, 01307, Germany
-
University of Marburg
Marburg, 35043, Germany
-
University of Munster
Münster, 48149, Germany
Conditions
Explore the condition pages connected to this study.